Several companies are currently in the process of public offerings, including Extreme Vision (06636), EPIWORLD (02726), TONGSHIFU (00664), HUAYAN ROBOTICS (01021), TONGRENTANGCARE (02667), DIAGENS-B (02526), and FOURSEMI (03625). As of March 23, brokerages such as Futu Securities and Tiger Brokers have provided margin financing of HK$6.04 billion for Extreme Vision, representing an oversubscription of over 241.98 times. For EPIWORLD, margin financing amounted to HK$1.379 billion, with an oversubscription of over 8.41 times. TONGSHIFU received HK$154 million in margin financing, oversubscribed by over 3.06 times. HUAYAN ROBOTICS saw margin financing of HK$23.814 billion, oversubscribed by over 346.79 times. TONGRENTANGCARE obtained HK$479 million in margin financing, oversubscribed by over 5.34 times. DIAGENS-B attracted HK$3.165 billion in margin financing, oversubscribed by over 35.17 times. FOURSEMI received HK$208 million in margin financing, oversubscribed by over 6.92 times.